Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Catheter Precision ( (VTAK) ) has shared an announcement.
On January 29, 2025, Catheter Precision, Inc.’s Board of Directors approved incentive stock options for executives as part of the 2023 Executive Incentive Plan. David Jenkins, CEO, received options for 450,000 shares, while Marie-Claude Jacques, Chief Commercial Officer, was granted options for 250,000 shares, with vesting tied to time and sales targets. This move aims to align the executives’ interests with company performance and enhance stakeholder value.
More about Catheter Precision
YTD Price Performance: -13.14%
Average Trading Volume: 405,254
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.12M
See more insights into VTAK stock on TipRanks’ Stock Analysis page.
